Blister Packs Pharmaceutical Packaging Market Size, Share & Industry Analysis, By Material (Plastic {Polyethylene terephthalate (PET), Polyethylene (PE), Polyvinyl chloride (PVC) and Others}, Aluminium, and Paper & Paperboard), By Product Type (Clamshell and Carded), By Application (Tablets & Capsules, Ampoules & Vials, and Others), and Regional Forecast, 2025-2032

The global blister packs pharmaceutical packaging market size was valued at USD 9.06 billion in 2024. The market is projected to grow from USD 9.47 billion in 2025 to USD 13.62 billion by 2032, exhibiting a CAGR of 5.23% during the forecast period. North America dominated the blister packs pharmaceutical packaging market with a market share of 27.04% in 2024.

Blister packs represent a widely used form of pharmaceutical packaging where a single dose of medication, such as tablets or capsules, is inserted into pre-formed plastic pockets or "blisters" and subsequently sealed with a cover. The market is growing due to the increasing need for tamper-evident, durable, and compliance-friendly packaging for solid-dose pharmaceuticals. Blister packs offer numerous advantages, such as extended shelf life, accurate dosage, improved patient compliance, cost-effective packaging for unit-dose medications, and enhanced protection against contamination and counterfeiting.

Amcor Plc and ACG Pharmapack Pvt. Ltd are the leading manufacturers, accounting for the largest global market share.

MARKET DYNAMICS

MARKET DRIVERS

Increasing Focus on Sustainable Packaging Initiatives Drives Market Growth

Blister packaging manufacturers are adopting eco-friendly materials in response to global sustainability goals. These include biodegradable and recyclable plastic films (such as PET and PLA), reduction in the use of vinyl and aluminum, and introduction of post-consumer recycled content films. This trend in the global blister packs pharmaceutical packaging market is further driven by regulatory frameworks in Europe and North America requiring lower carbon footprints in pharmaceutical packaging. It also involves creating mono-material blister packs that streamline the recycling process by utilizing only one type of recyclable material. Moreover, there is an increasing focus on using post-consumer recycled resources in the creation of new blister packs and the growing pharmaceutical sector in emerging nations. It thus drives the global market growth.

• The Press Information Bureau (PIB) states that India's pharmaceutical sector for FY 2023-24 was estimated at USD 50 billion, with domestic usage at USD 23.5 billion and exports at USD 26.5 billion. India's pharmaceutical sector is regarded as the third largest globally by volume and ranks 14th for production value.

MARKET RESTRAINTS

Stringent Regulatory Environment Restrain the Market Expansion

The pharmaceutical packaging sector functions in a highly controlled environment to guarantee product safety, effectiveness, and patient health. Regulations cover multiple facets, such as material compatibility, tamper-proof features, child-resistant packaging, and precise labeling, focusing on preventing harm and ensuring product integrity. Pharmaceutical blister packaging must comply with FDA and EMA labeling standards, tamper evidence and anti-counterfeiting guidelines, and serialization and track-and-trace systems. This makes manufacturing more complex, thus restraining the supply chain, increasing costs for global players, and hampering global blister packs pharmaceutical packaging market growth.

MARKET OPPORTUNITIES

Integration of Digital Solutions Will Offer Lucrative Growth Opportunities for the Market

The future of the blister packaging industry in the pharmaceutical sector is set to experience substantial progress, emphasizing the improvement of patient safety and the incorporation of intelligent technologies. Pharmaceutical companies are integrating sensors or chips to track medication usage or expiration, facilitating improved patient compliance and minimizing waste. The integration of digital solutions in blister packs includes linking QR codes to patient instructions and digital prescriptions, RFID tags for tracking and anti-counterfeit measures, and digital adherence technologies to monitor dosage. These innovations are enhancing patient engagement and medication safety, thus offering growth opportunities.

BLISTER PACKS PHARMACEUTICAL PACKAGING MARKET TRENDS

Automation and Digitalization in Blisters Emerges as a Key Trend

Blister packs are being created to facilitate easy opening and resealing, thereby improving the user experience. Innovations in automation and digitalization are revolutionizing blister packaging, increasing efficiency, quality, and traceability. Technologies associated with Industry 4.0, such as AI, IoT, and robotics, are being adopted to develop smarter and more adaptable production lines. This encompasses predictive maintenance, AI-driven defect detection, and the use of digital twins for optimizing processes. Systems utilizing AI for inspection can identify defects with great precision, ensuring consistent product quality. The incorporation of advanced technologies like AI, IoT, and robotics is enhancing both production efficiency and quality control. This form of blister packaging is becoming increasingly popular due to its adaptability, smart features, and visual attractiveness, making it well-suited for retail displays and contributing to its rise as a significant market trend.

Download Free sample to learn more about this report.

Segmentation Analysis

By Material

Potential Benefits Offered by Plastic Material Boosted the Segmental Growth

Based on material, the market is divided into plastic, aluminium, and paper & paperboard.

The plastic segment accounted for the larger share of the market in 2024. Plastic materials provide superior preservation and safeguard product quality. The items are easily seen, and since the material is sturdy, it can safeguard the medications from moisture and gases, thereby boosting the segmental growth in the global market.

Paper and paperboard material will continue to account for a considerable share of the market over the forecast period. Paper and paperboard blister packs tend to be eco-friendly packaging options as they can be recycled and utilize less plastic. They also provide simpler access for customers and can display the product efficiently.

By Product Type

Cost Effectiveness of Carded Blister Packs Boosted the Segmental Growth

Based on product type, the market is divided into clamshell and carded.

The carded segment accounted for the larger share of the market in 2024. Carded product types provide an economical and important way to package tablets, capsules, and various nutraceutical items. The items are convenient to store and transport since they occupy minimal space when enclosed in carded pharmaceutical blisters. Carded blister packaging provides numerous advantages, such as enhanced product visibility, protection against damage and tampering, and affordability. It further enables a clear showcase of products and offers room for branding and details.

Clamshell product type will continue to account for a considerably larger share of the market during the forecast period. They offer protection from moisture, UV rays, and contamination, ensuring product integrity and shelf life, thus enhancing segmental growth.

By Application

Increase in Health-related Problems Drives the Tablets and Capsules Segment’s Growth

Based on the application, the market is segmented into tablets & capsules, ampoules & vials, and others.

Tablets and capsules are the dominating segment in the market in 2024. This segment is expected to experience substantial growth during the forecast period. Pharma blister packaging is primarily utilized for tablets and capsules as blisters are budget-friendly, child-proof, and ensure excellent product integrity. The increase in health-related problems and the use of tablets and capsules propel the segmental growth.

On the other hand, the ampoules and vials segment is expected to witness steady growth during the forecast period. Blister packs provide enhanced product protection, improved shelf life, and easier dose management, which, in turn, increases their usage for ampoules and vials.

Blister Packs Pharmaceutical Packaging Market Regional Outlook

By geography, the market is categorized into North America, Europe, Asia Pacific, and the Rest of the World.

North America

To get more information on the regional analysis of this market, Download Free sample

North America is the dominating region in the global blister packs pharmaceutical packaging market share. The growth of the market is aided by the region's robust healthcare infrastructure and the existence of leading pharmaceutical firms. Furthermore, the presence of key market participants and increasing spending on healthcare in the region also aid in the growth of the market.

• According to the American Medical Association, in 2023, health expenditures in the U.S. rose by 7.5% to reach USD 4.9 trillion, equating to USD 14,570 for each person. This growth rate is considerably above the 4.6% increase in 2022, and except for the 10.4% surge in 2020 caused by the COVID-19 pandemic, it marks the highest growth rate seen since 2003 (8.5%).

Europe

Europe is a significant market for blister packs and pharmaceutical packaging in the global market. There is a strong focus on circular economy practices in various countries such as Germany, France, and others. Several organizations and governments enforce regulations for recyclable packaging, which, in turn, boosts the demand for blister packs. High consumption of OTC medications in blister format also promotes market growth in Europe. The growing investments in production lines enhance the market growth.

• For instance, in March 2025, Aenova, a contract manufacturer and developer for the healthcare and pharmaceutical sectors, announced the growth of its Bad Aibling facility. Investing approximately USD 21.65 million in new production and packaging lines, the facility provides a contemporary, high-capacity infrastructure for manufacturing effervescent products and blister packaging.

Asia Pacific

Asia Pacific is the second-largest market due to pharmaceutical growth in China, India, and South Korea. The augmenting generics production and rising healthcare investments fuel demand for blister packs, thus driving the market growth. Furthermore, government initiatives for localizing pharma manufacturing also aid in the market expansion. Rising exports of pharmaceutical products enhance market growth.

• According to the India Brand Equity Foundation, India's pharmaceutical exports jumped to USD 25.4 billion in 2023, marking a significant rise from USD 17.3 billion. This increasing trend is expected to persist, further driving the need for pharmaceutical blister packs in the country for more secure deliveries.

Middle East & Africa

The market in the Middle East & Africa region is expected to witness considerable growth in the near future. The Middle East & Africa region is an emerging market due to infrastructure expansion and rising local pharma output. It thus generates demand for blister packs, further driving the market growth.

Latin America

Latin America market will experience moderate growth in the forthcoming years. The high demand for secure, low-cost, and stable packaging options will boost market development in the Latin American region.

COMPETITIVE LANDSCAPE

Key Industry Players

Continuous Development and Introduction of New Products by Key Companies Resulted in Their Dominating Positions

The global blister packs pharmaceutical packaging market is concentrated with companies such as Amcor Plc, ACG Pharmapack Pvt. Ltd., AptarGroup, Inc., Constantia Flexibles GmbH, Bilcare Research Inc., and Ecobliss Pharmaceutical Packaging, accounting for a significant market share.

Amcor is a global leader in developing and producing packaging solutions, focusing on responsible and sustainable practices. They offer a wide range of flexible and rigid packaging, specialty cartons, closures, and services for various industries, including food, beverage, pharmaceutical, medical, and personal care. Their mission is to be the premier global packaging company, generating value for customers, employees, investors, and the environment.

ACG Pharmapack Pvt. Ltd., now part of Smurfit Westrock, is a global leader in paper-based packaging solutions with a strong presence in Europe and America. The company offers a wide range of products, including corrugated packaging, containerboard, and recycling solutions, and has a significant focus on sustainability and innovation. The company manufactures corrugated packaging, containerboard, solid board, and folding cartons, with a focus on innovative and sustainable solutions.

Additionally, AptarGroup, Inc. and Constantia Flexibles GmbH are among the other prominent players in the market. Their growing focus on significant investments in the research & development of innovative products has supported the companies’ share in the market.

• In May 2022, Aptar CSP Technologies, a division of AptarGroup, Inc. and a pioneer in active material science solutions that guarantee product safety, prolong shelf life, and enhance patient experience, revealed a new manufacturing facility capable of producing its Activ-Blister™ Solutions for oral slide dose medications in Europe.

LIST OF KEY BLISTER PACKS PHARMACEUTICAL PACKAGING COMPANIES PROFILED

• Amcor Plc (Switzerland)
• ACG Pharmapack Pvt. Ltd. (India)
• AptarGroup, Inc. (U.S.)
• Constantia Flexibles GmbH (Austria)
• Bilcare Research Inc. (India)
• Ecobliss Pharmaceutical Packaging (Netherlands)
• Honeywell International Inc. (U.S.)
• Pharma Packaging Solutions (U.S.)
• Klöckner Pentaplast (Luxembourg)
• Rohrer Corporation (U.S.)
• Sonoco Products Company (U.S.)
• Sharp Services LLC (U.S.)
• Steripack (U.K.)
• Catty Corporation (U.S.)
• Competent Packaging Industries (India)

KEY INDUSTRY DEVELOPMENTS:

• June 2024: Keystone Folding Box, a specialist in paperboard packaging, introduced a paperboard blister wallet for pharmaceutical tablets called Push-Pak. The straightforward push-through opening mechanism of the solution removes the necessity for complex opening guidelines while featuring a more compact blister layout that decreases the total size of the package.
• June 2024: Aluflexpack AG launched an innovative sustainable packaging solution that will mainly be utilized in the pharmaceutical sector, yet may also have broader applications. 4∞ Form is a blister pack made completely of coated aluminium, ensuring it is ideal for recycling, has a minimal CO2 footprint, and offers remarkable protective features.
• January 2024: TekniPlex Healthcare teamed up with Alpek Polyester to launch pharmaceutical-grade polyethylene terephthalate (PET) blister film that includes substantial recycled content. Appropriate for various primary packaging uses, 30% of the PET blister film is produced with post-consumer recycled (PCR) monomers.
• November 2023: Schreiner MediPharm provides an extensive range of intelligent blister packs for clinical studies. The collaboration with packaging expert Keystone Folding Box Co., a leader in the pharmaceutical sector, enhanced Schreiner MediPharm’s offerings with a solution that is especially safe for children and accessible for seniors. The incorporation of integrated electronics transforms blister packaging into an e-diary that records dosing history data in real time.
• April 2022: Huhtamaki introduced a PET blister lidding solution for the worldwide healthcare sector. Huhtamaki's Push Tab blister lid is made of mono-material PET and contains no aluminium. It was created to fulfill the strict safety standards of heavily regulated pharmaceutical and healthcare packaging, offering the industry a more sustainable option compared to conventional push-through blister packaging.

REPORT COVERAGE

To gain extensive insights into the market, Download for Customization

Report Scope & Segmentation